The role of bacterial biofilms in chronic infections

APMIS

Volumn 121, Issue SUPPL.136, 2013, Pages 1-58

  Bjarnsholt, Thomas ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Biofilms; Chronic infections

Indexed keywords

ANTIBIOTIC AGENT; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; N ACYLHOMOSERINE LACTONE; PEPTIDE NUCLEIC ACID;

ACTIVATED SLUDGE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BIOFILM; CHRONIC OTITIS MEDIA; CHRONIC WOUND; CLOSTRIDIUM DIFFICILE INFECTION; CONFOCAL LASER MICROSCOPY; CYSTIC FIBROSIS; DNA SEQUENCE; DRUG TOLERANCE; ENTEROCOCCUS FAECALIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HUMAN; INFECTION PREVENTION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; RHIZOSPHERE; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS SANGUINIS; VIBRIO FISCHERI;

EID: 84877118787     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12099     Document Type: Article

References (381)

1. Burmolle M, Thomsen TR, Fazli M, Dige I, Christensen L, Homoe P, et al. Biofilms in chronic infections - a matter of opportunity - monospecies biofilms in multispecies infections. FEMS Immunol Med Microbiol 2010;59:324-36.
2. Atlas RM, Bartha R. Microbial Ecology, 4th ed. Menlo Park, CA: Benjamin/Cummings Science Publishing, 1997.
3. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial biofilms. Annu Rev Microbiol 1995;49:711-45.
4. Potera C. Studying slime. Environ Health Perspect 1998;106:A604-6.
5. van Leeuwenhoek A. Microscopical observations about animals in the scurf of the teeth. Philos Trans R Soc Lond B Biol Sci 1684;14:568-74.
6. Henrici AT. Studies of freshwater bacteria. J Bacteriol 1933;25:2132.
7. Rogovska T, Lazareva MF. Microbiological characteristics of biofilm purifying hydrogen sulphide containing sewage. 1961.
8. Høiby N. Pseudomonas aeruginosa infection in cystic fibrosis. University of Copenhagen, 1977.
9. Costerton JW, Geesey GG, Cheng KJ. How bacteria stick. Sci Am 1978;238:86-95.
10. McCoy WF, Bryers JD, Robbins J, Costerton JW. Observations of fouling biofilm formation. Can J Microbiol 1981;27:910-7.
11. Costerton JW, Cheng KJ, Geesey GG, Ladd TI, Nickel JC, Dasgupta M, et al. Bacterial biofilms in nature and disease. Annu Rev Microbiol 1987;41:435-64.
12. Costerton JW, Lewandowski Z, DeBeer D, Caldwell D, Korber D, James G. Biofilms, the customized microniche. J Bacteriol 1994;176:2137-42.
13. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999;284:1318-22.
14. Costerton JW. Replacement of acute planctonic by chronic biofilm diseases. In: Eckey C, editor. The Biofilm Primer. New York: Springer, 2007;129-61.
15. Bayles KW. The biological role of death and lysis in biofilm development. Nat Rev Microbiol 2007;5:721-6.
16. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 2010;35:322-32.
17. Anwar H, van Biesen T, Dasgupta M, Lam K, Costerton JW. Interaction of biofilm bacteria with antibiotics in a novel in vitro chemostat system. Antimicrob Agents Chemother 1989;33:1824-6.
18. Donlan RM. Biofilms: microbial life on surfaces. Emerg Infect Dis 2002;8:881-90.
19. Zimmerli W, Trampuz A. Implant-associated infection. In: Bjarnsholt T, Moser C, Jensen PO, Høiby N, editors. Biofilm Infections. New York: Springer, 2010: 91-110.
20. Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet 2011;378:1015-26.
21. Maraffi T, Piffer F, Cosentini R. Prophylactic antibiotic therapy in chronic obstructive pulmonary disease. Ther Adv Respir Dis 2010;4:135-42.
22. Klausen M, aes-Jorgensen A, Molin S, Tolker-Nielsen T. Involvement of bacterial migration in the development of complex multicellular structures in Pseudomonas aeruginosa biofilms. Mol Microbiol 2003;50:61-8.
23. Klausen M, Heydorn A, Ragas P, Lambertsen L, aes-Jorgensen A, Molin S, et al. Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants. Mol Microbiol 2003 Jun;48:1511-24.
24. Sauer K, Camper AK, Ehrlich GD, Costerton JW, Davies DG. Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol 2002;184:1140-54.
25. Alhede M, Kragh KN, Qvortrup K, lesen-Holm M, van GM, Christensen LD, et al. Phenotypes of non-attached Pseudomonas aeruginosa aggregates resemble surface attached biofilm. PLoS ONE 2011;6:e27943.
26. Christensen BB, Sternberg C, Andersen JB, Palmer RJ Jr, Nielsen AT, Givskov M, et al. Molecular tools for study of biofilm physiology. Methods Enzymol 1999;310:20-42.
27. Christensen BB, Haagensen JA, Heydorn A, Molin S. Metabolic commensalism and competition in a two-species microbial consortium. Appl Environ Microbiol 2002;68:2495-502.
28. Gjermansen M, Ragas P, Sternberg C, Molin S, Tolker-Nielsen T. Characterization of starvation-induced dispersion in Pseudomonas putida biofilms. Environ Microbiol 2005;7:894-906.
29. Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, et al. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 2000;406:959-64.
30. Bjarnsholt T, Givskov M. The role of quorum sensing in the pathogenicity of the cunning aggressor Pseudomonas aeruginosa. Anal Bioanal Chem 2006;387(2):409-14.
31. Sandt C, Smith-Palmer T, Pink J, Brennan L, Pink D. Confocal Raman microspectroscopy as a tool for studying the chemical heterogeneities of biofilms in situ. J Appl Microbiol 2007;103:1808-20.
32. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 2002;109:317-25.
33. Kolpen M, Hansen CR, Bjarnsholt T, Moser C, Christensen LD, van GM, et al. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax 2010;65:57-62.
34. Walters MC III, Roe F, Bugnicourt A, Franklin MJ, Stewart PS. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother 2003;47:317-23.
35. Semmler AB, Whitchurch CB, Mattick JS. A re-examination of twitching motility in Pseudomonas aeruginosa. Microbiology 1999;145(Pt 10):2863-73.
36. O'Toole G, Kaplan HB, Kolter R. Biofilm formation as microbial development. Annu Rev Microbiol 2000;54:49-79.
37. Sauer K. The genomics and proteomics of biofilm formation. Genome Biol 2003;4:219.
38. Purevdorj B, Costerton JW, Stoodley P. Influence of hydrodynamics and cell signaling on the structure and behavior of Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 2002;68:4457-64.
39. Reimmann C, Ginet N, Michel L, Keel C, Michaux P, Krishnapillai V, et al. Genetically programmed autoinducer destruction reduces virulence gene expression and swarming motility in Pseudomonas aeruginosa PAO1. Microbiology 2002;148(Pt 4):923-32.
40. Hentzer M, Eberl L, Givskov M. Transcriptome analysis of Pseudomonas aeruginosa biofilm development: anaerobic respiration and iron limitation. Biofilms 2005;2:37-61.
41. Folsom JP, Richards L, Pitts B, Roe F, Ehrlich GD, Parker A, et al. Physiology of Pseudomonas aeruginosa in biofilms as revealed by transcriptome analysis. BMC Microbiol 2010;10:294.
42. Lee B, Haagensen JA, Ciofu O, Andersen JB, Høiby N, Molin S. Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis. J Clin Microbiol 2005;43:5247-55.
43. Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 1998;280:295-8.
44. Bjarnsholt T, Jensen PO, Burmolle M, Hentzer M, Haagensen JA, Hougen HP, et al. Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. Microbiology 2005;151(Pt 2):373-83.
45. Stoodley P, Sauer K, Davies DG, Costerton JW. Biofilms as complex differentiated communities. Annu Rev Microbiol 2002;56:187-209.
46. Kreft JU, Bonhoeffer S. The evolution of groups of cooperating bacteria and the growth rate versus yield trade-off. Microbiology 2005;151(Pt 3):637-41.
47. Kreft JU. Biofilms promote altruism. Microbiology 2004;150(Pt 8):2751-60.
48. Monds RD, O'Toole GA. The developmental model of microbial biofilms: 10 years of a paradigm up for review. Trends Microbiol 2009;17:73-87.
49. Conibear TC, Collins SL, Webb JS. Role of mutation in Pseudomonas aeruginosa biofilm development. PLoS ONE 2009;4:e6289.
50. Stoodley P, Wilson S, Hall-Stoodley L, Boyle JD, Lappin-Scott HM, Costerton JW. Growth and detachment of cell clusters from mature mixed-species biofilms. Appl Environ Microbiol 2001;67:5608-13.
51. Stapper AP, Narasimhan G, Ohman DE, Barakat J, Hentzer M, Molin S, et al. Alginate production affects Pseudomonas aeruginosa biofilm development and architecture, but is not essential for biofilm formation. J Med Microbiol 2004;53(Pt 7):679-90.
52. Webb JS, Thompson LS, James S, Charlton T, Tolker-Nielsen T, Koch B, et al. Cell death in Pseudomonas aeruginosa biofilm development. J Bacteriol 2003;185:4585-92.
53. Rupp CJ, Fux CA, Stoodley P. Viscoelasticity of Staphylococcus aureus biofilms in response to fluid shear allows resistance to detachment and facilitates rolling migration. Appl Environ Microbiol 2005;71:2175-8.
54. Abraham J, Mansour C, Veledar E, Khan B, Lerakis S. Staphylococcus aureus bacteremia and endocarditis: the Grady Memorial Hospital experience with methicillin-sensitive S aureus and methicillin-resistant S aureus bacteremia. Am Heart J 2004;147:536-9.
55. Fatkenheuer G, Cornely O, Seifert H. Clinical management of catheter-related infections. Clin Microbiol Infect 2002;8:545-50.
56. Jefferson KK. What drives bacteria to produce a biofilm? FEMS Microbiol Lett 2004;236:163-73.
57. Zogaj X, Nimtz M, Rohde M, Bokranz W, Romling U. The multicellular morphotypes of Salmonella typhimurium and Escherichia coli produce cellulose as the second component of the extracellular matrix. Mol Microbiol 2001;39:1452-63.
58. Schramm M, Hestrin S. Factors affecting production of cellulose at the air/liquid interface of a culture of Acetobacter xylinum. J Gen Microbiol 1954;11:123-9.
59. Ma L, Conover M, Lu H, Parsek MR, Bayles K, Wozniak DJ. Assembly and development of the Pseudomonas aeruginosa biofilm matrix. PLoS Pathog 2009;5:e1000354.
60. Allesen-Holm M, Barken KB, Yang L, Klausen M, Webb JS, Kjelleberg S, et al. A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol Microbiol 2006;59:1114-28.
61. Whitchurch CB, Tolker-Nielsen T, Ragas PC, Mattick JS. Extracellular DNA required for bacterial biofilm formation. Science 2002;295:1487.
62. Mann EE, Rice KC, Boles BR, Endres JL, Ranjit D, Chandramohan L, et al. Modulation of eDNA release and degradation affects Staphylococcus aureus biofilm maturation. PLoS ONE 2009;4:e5822.
63. Rice KC, Mann EE, Endres JL, Weiss EC, Cassat JE, Smeltzer MS, et al. The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus. Proc Natl Acad Sci USA 2007;104:8113-8.
64. Borlee BR, Goldman AD, Murakami K, Samudrala R, Wozniak DJ, Parsek MR. Pseudomonas aeruginosa uses a cyclic-di-GMP-regulated adhesin to reinforce the biofilm extracellular matrix. Mol Microbiol 2010;75:827-42.
65. Fexby S, Bjarnsholt T, Jensen PO, Roos V, Høiby N, Givskov M, et al. Biological Trojan horse: antigen 43 provides specific bacterial uptake and survival in human neutrophils. Infect Immun 2007;75:30-4.
66. Klemm P, Hjerrild L, Gjermansen M, Schembri MA. Structure-function analysis of the self-recognizing Antigen 43 autotransporter protein from Escherichia coli. Mol Microbiol 2004;51:283-96.
67. Matsuyama T, Kaneda K, Ishizuka I, Toida T, Yano I. Surface-active novel glycolipid and linked 3-hydroxy fatty acids produced by Serratia rubidaea. J Bacteriol 1990 Jun;172:3015-22.
68. Davey ME, Caiazza NC, O'Toole GA. Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1. J Bacteriol 2003;185:1027-36.
69. Pamp SJ, Tolker-Nielsen T. Multiple roles of biosurfactants in structural biofilm development by Pseudomonas aeruginosa. J Bacteriol 2007;189:2531-9.
70. Pamp S, Gjermansen M, Tolker-Nielsen T. The biofilm matrix - a sticky framework. In: Kjelleberg S, Givskov M, editors. Bacterial Biofilm Formation and Adaptation. Norwich, UK: Horizon BioScience, 2007: 37-69.
71. Harmsen M, Yang L, Pamp SJ, Tolker-Nielsen T. An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal. FEMS Immunol Med Microbiol 2010;59:253-68.
72. Parsek MR, Tolker-Nielsen T. Pattern formation in Pseudomonas aeruginosa biofilms. Curr Opin Microbiol 2008;11:560-6.
73. Flemming HC, Neu TR, Wozniak DJ. The EPS matrix: the "house of biofilm cells". J Bacteriol 2007;189:7945-7.
74. Nivens DE, Ohman DE, Williams J, Franklin MJ. Role of alginate and its O acetylation in formation of Pseudomonas aeruginosa microcolonies and biofilms. J Bacteriol 2001;183:1047-57.
75. Simpson JA, Smith SE, Dean RT. Scavenging by alginate of free radicals released by macrophages. Free Radic Biol Med 1989;6:347-53.
76. Allison DG, Matthews MJ. Effect of polysaccharide interactions on antibiotic susceptibility of Pseudomonas aeruginosa. J Appl Bacteriol 1992;73:484-8.
77. Pedersen SS, Høiby N, Espersen F, Koch C. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis. Thorax 1992;47:6-13.
78. Pedersen SS, Espersen F, Høiby N, Shand GH. Purification, characterization, and immunological cross-reactivity of alginates produced by mucoid Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol 1989;27:691-9.
79. Høiby N. Understanding bacterial biofilms in patients with cystic fibrosis: current and innovative approaches to potential therapies. J Cyst Fibros 2002;1:249-54.
80. Høiby N. Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response. Acta Pathol Microbiol Scand [B] Microbiol Immunol 1974;82:551-8.
81. Wozniak DJ, Wyckoff TJ, Starkey M, Keyser R, Azadi P, O'Toole GA, et al. Alginate is not a significant component of the extracellular polysaccharide matrix of PA14 and PAO1 Pseudomonas aeruginosa biofilms. Proc Natl Acad Sci USA 2003;100:7907-12.
82. Bragonzi A, Worlitzsch D, Pier GB, Timpert P, Ulrich M, Hentzer M, et al. Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model. J Infect Dis 2005;192:410-9.
83. Byrd MS, Sadovskaya I, Vinogradov E, Lu H, Sprinkle AB, Richardson SH, et al. Genetic and biochemical analyses of the Pseudomonas aeruginosa Psl exopolysaccharide reveal overlapping roles for polysaccharide synthesis enzymes in Psl and LPS production. Mol Microbiol 2009;73:622-38.
84. Ryder C, Byrd M, Wozniak DJ. Role of polysaccharides in Pseudomonas aeruginosa biofilm development. Curr Opin Microbiol 2007;10:644-8.
85. Alhede M, Qvortrup K, Liebrechts R, Hoiby N, Givskov M, Bjarnsholt T. Combination of microscopic techniques reveals a comprehensive visual impression of biofilm structure and composition. FEMS Immunol Med Microbiol 2012;Jul;65(2):335-42.
86. Joubert LM, Wolfaardt GM, Botha A. Microbial exopolymers link predator and prey in a model yeast biofilm system. Microb Ecol 2006;52:187-97.
87. Alipour M, Suntres ZE, Omri A. Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa. J Antimicrob Chemother 2009;64:317-25.
88. Alipour M, Suntres ZE, Halwani M, Azghani AO, Omri A. Activity and interactions of liposomal antibiotics in presence of polyanions and sputum of patients with cystic fibrosis. PLoS ONE 2009;4:e5724.
89. Schooling SR, Beveridge TJ. Membrane vesicles: an overlooked component of the matrices of biofilms. J Bacteriol 2006;188:5945-57.
90. Sedghizadeh PP, Kumar SK, Gorur A, Schaudinn C, Shuler CF, Costerton JW. Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy. J Am Dent Assoc 2009;140:1259-65.
91. Nielsen LP, Risgaard-Petersen N, Fossing H, Christensen PB, Sayama M. Electric currents couple spatially separated biogeochemical processes in marine sediment. Nature 2010;463:1071-4.
92. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002;15:167-93.
93. Drenkard E. Antimicrobial resistance of Pseudomonas aeruginosa biofilms. Microbes Infect 2003;5:1213-9.
94. Drenkard E, Ausubel FM. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 2002;416:740-3.
95. Bagge N, Hentzer M, Andersen JB, Ciofu O, Givskov M, Høiby N. Dynamics and spatial distribution of beta-lactamase expression in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 2004;48:1168-74.
96. Peterson AA, Fesik SW, McGroarty EJ. Decreased binding of antibiotics to lipopolysaccharides from polymyxin-resistant strains of Escherichia coli and Salmonella typhimurium. Antimicrob Agents Chemother 1987;31:230-7.
97. Kohler T, van Delden C, Curty LK, Hamzehpour MM, Pechere JC. Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa. J Bacteriol 2001;183:5213-22.
98. Sawada I, Maseda H, Nakae T, Uchiyama H, Nomura N. A quorum-sensing autoinducer enhances the mexAB-oprM efflux-pump expression without the MexR-mediated regulation in Pseudomonas aeruginosa. Microbiol Immunol 2004;48:435-9.
99. Norman A, Hansen LH, Sorensen SJ. Conjugative plasmids: vessels of the communal gene pool. Philos Trans R Soc Lond B Biol Sci 2009;364:2275-89.
100. Canton R, Morosini MI. Emergence and spread of antibiotic resistance following exposure to antibiotics. FEMS Microbiol Rev 2011;35:977-91.
101. Giedraitiene A, Vitkauskiene A, Naginiene R, Pavilonis A. Antibiotic resistance mechanisms of clinically important bacteria. Medicina (Kaunas) 2011;47:137-46.
102. Ciofu O, Giwercman B, Pedersen SS, Høiby N. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center. APMIS 1994;102:674-80.
103. Tenover FC. Mechanisms of antimicrobial resistance in bacteria. Am J Infect Control 2006;34(5 Suppl 1):S3-10.
104. Mulcahy H, Charron-Mazenod L, Lewenza S. Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLoS Pathog 2008;4:e1000213.
105. Stewart PS, Franklin MJ. Physiological heterogeneity in biofilms. Nat Rev Microbiol 2008;6:199-210.
106. Werner E, Roe F, Bugnicourt A, Franklin MJ, Heydorn A, Molin S, et al. Stratified growth in Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 2004;70:6188-96.
107. Lenz AP, Williamson KS, Pitts B, Stewart PS, Franklin MJ. Localized gene expression in Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 2008;74:4463-71.
108. Hoyle BD, Costerton JW. Bacterial resistance to antibiotics: the role of biofilms. Prog Drug Res 1991;37:91-105.
109. Bjarnsholt T, Givskov M. Quorum sensing inhibitory drugs as next generation antimicrobials: worth the effort? Curr Infect Dis Rep 2008;10:22-8.
110. Brown MR, Allison DG, Gilbert P. Resistance of bacterial biofilms to antibiotics: a growth-rate related effect? J Antimicrob Chemother 1988;22:777-80.
111. Kim J, Hahn JS, Franklin MJ, Stewart PS, Yoon J. Tolerance of dormant and active cells in Pseudomonas aeruginosa PA01 biofilm to antimicrobial agents. J Antimicrob Chemother 2009;63:129-35.
112. Roberts ME, Stewart PS. Modeling antibiotic tolerance in biofilms by accounting for nutrient limitation. Antimicrob Agents Chemother 2004;48:48-52.
113. Borriello G, Werner E, Roe F, Kim AM, Ehrlich GD, Stewart PS. Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrob Agents Chemother 2004;48:2659-64.
114. Teitzel GM, Parsek MR. Heavy metal resistance of biofilm and planktonic Pseudomonas aeruginosa. Appl Environ Microbiol 2003;69:2313-20.
115. Pamp SJ, Gjermansen M, Johansen HK, Tolker-Nielsen T. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol Microbiol 2008;68:223-40.
116. Haagensen JA, Klausen M, Tolker-Nielsen T, Ernst RK, Miller SI, Molin S. Differentiation and distribution of colistin/SDS tolerant cells in Pseudomonas aeruginosa flow-cell biofilms. J Bacteriol 2006;189:28-37.
117. Marciano-Cabral F, Cabral G. Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev 2003;16:273-307.
118. Parry JD. Protozoan grazing of freshwater biofilms. Adv Appl Microbiol 2004;54:167-96.
119. Nussler AK, Wittel UA, Nussler NC, Beger HG. Leukocytes, the Janus cells in inflammatory disease. Langenbecks Arch Surg 1999;384:222-32.
120. Leid JG, Shirtliff ME, Costerton JW, Stoodley AP. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect Immun 2002;70:6339-45.
121. Matz C, Webb JS, Schupp PJ, Phang SY, Penesyan A, Egan S, et al. Marine biofilm bacteria evade eukaryotic predation by targeted chemical defense. PLoS ONE 2008;3:e2744.
122. Matz C, Bergfeld T, Rice SA, Kjelleberg S. Microcolonies, quorum sensing and cytotoxicity determine the survival of Pseudomonas aeruginosa biofilms exposed to protozoan grazing. Environ Microbiol 2004;6:218-26.
123. Matz C, McDougald D, Moreno AM, Yung PY, Yildiz FH, Kjelleberg S. Biofilm formation and phenotypic variation enhance predation-driven persistence of Vibrio cholerae. Proc Natl Acad Sci USA 2005;102:16819-24.
124. Baltimore RS, Christie CD, Smith GJ. Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration. Am Rev Respir Dis 1989;140:1650-61.
125. Alhede M, Bjarnsholt T, Jensen PO, Phipps RK, Moser C, Christophersen L, et al. Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes. Microbiology 2009;155(Pt 11):3500-8.
126. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet 2001;358:135-8.
127. Høiby N, Krogh JH, Moser C, Song Z, Ciofu O, Kharazmi A. Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect 2001;3:23-35.
128. Bjarnsholt T, Jensen PO, Rasmussen TB, Christophersen L, Calum H, Hentzer M, et al. Garlic blocks quorum sensing and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infections. Microbiology 2005;151(Pt 12):3873-80.
129. Pernthaler J. Predation on prokaryotes in the water column and its ecological implications. Nat Rev Microbiol 2005;3:537-46.
130. Matz C, Moreno AM, Alhede M, Manefield M, Hauser AR, Givskov M, et al. Pseudomonas aeruginosa uses type III secretion system to kill biofilm-associated amoebae. ISME J 2008;2:843-52.
131. Yang L, Haagensen JA, Jelsbak L, Johansen HK, Sternberg C, Hoiby N, et al. In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections. J Bacteriol 2008;190:2767-76.
132. Fuqua WC, Winans SC, Greenberg EP. Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulators. J Bacteriol 1994;176:269-75.
133. Manefield M, Turner SL. Quorum sensing in context: out of molecular biology and into microbial ecology. Microbiology 2002;148(Pt 12):3762-4.
134. Lerat E, Moran NA. The evolutionary history of quorum-sensing systems in bacteria. Mol Biol Evol 2004;21:903-13.
135. Tomasz A. Control of the competent state in Pneumococcus by a hormone-like cell product: an example for a new type of regulatory mechanism in bacteria. Nature 1965;208:155-9.
136. Nealson KH, Platt T, Hastings JW. Cellular control of the synthesis and activity of the bacterial luminescent system. J Bacteriol 1970;104:313-22.
137. Latifi A, Winson MK, Foglino M, Bycroft BW, Stewart GS, Lazdunski A, et al. Multiple homologues of LuxR and LuxI control expression of virulence determinants and secondary metabolites through quorum sensing in Pseudomonas aeruginosa PAO1. Mol Microbiol 1995;17:333-43.
138. Hentzer M, Wu H, Andersen JB, Riedel K, Rasmussen TB, Bagge N, et al. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J 2003;22:3803-15.
139. Wagner VE, Bushnell D, Passador L, Brooks AI, Iglewski BH. Microarray analysis of Pseudomonas aeruginosa quorum-sensing regulons: effects of growth phase and environment. J Bacteriol 2003;185:2080-95.
140. Schuster M, Lostroh CP, Ogi T, Greenberg EP. Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: a transcriptome analysis. J Bacteriol 2003;185:2066-79.
141. O'Sullivan DJ, O'Gara F. Traits of fluorescent Pseudomonas spp. involved in suppression of plant root pathogens. Microbiol Rev 1992;56:662-76.
142. Rasmussen TB, Bjarnsholt T, Skindersoe ME, Hentzer M, Kristoffersen P, Kote M, et al. Screening for quorum-sensing inhibitors (QSI) by use of a novel genetic system, the QSI selector. J Bacteriol 2005;187:1799-814.
143. Rasmussen TB, Skindersoe ME, Bjarnsholt T, Christensen KB, Andersen JB, Ostenfeld-Larsen T, et al. Idendity and effects of quorum sensing inhibitors produced by Penicillum species. Microbiology 2005;151:1325-40.
144. Wu H, Song Z, Givskov M, Doring G, Worlitzsch D, Mathee K, et al. Pseudomonas aeruginosa mutations in lasI and rhlI quorum sensing systems result in milder chronic lung infection. Microbiology 2001;147(Pt 5):1105-13.
145. Ochsner UA, Reiser J. Autoinducer-mediated regulation of rhamnolipid biosurfactant synthesis in Pseudomonas aeruginosa. Proc Natl Acad Sci USA 1995;92:6424-8.
146. Rahim R, Ochsner UA, Olvera C, Graninger M, Messner P, Lam JS, et al. Cloning and functional characterization of the Pseudomonas aeruginosa rhlC gene that encodes rhamnosyltransferase 2, an enzyme responsible for di-rhamnolipid biosynthesis. Mol Microbiol 2001;40:708-18.
147. Shih PC, Huang CT. Effects of quorum-sensing deficiency on Pseudomonas aeruginosa biofilm formation and antibiotic resistance. J Antimicrob Chemother 2002;49:309-14.
148. Hentzer M, Riedel K, Rasmussen TB, Heydorn A, Andersen JB, Parsek MR, et al. Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiology 2002;148(Pt 1):87-102.
149. Hassett DJ, Ma JF, Elkins JG, McDermott TR, Ochsner UA, West SE, et al. Quorum sensing in Pseudomonas aeruginosa controls expression of catalase and superoxide dismutase genes and mediates biofilm susceptibility to hydrogen peroxide. Mol Microbiol 1999;34:1082-93.
150. Christensen LD, van GM, Jakobsen TH, Alhede M, Hougen HP, Hoiby N, et al. Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model. J Antimicrob Chemother 2012;May;67(5):1198-206.
151. Fuqua C, Parsek MR, Greenberg EP. Regulation of gene expression by cell-to-cell communication: acyl- homoserine lactone quorum sensing. Annu Rev Genet 2001;35:439-68.
152. Taga ME, Bassler BL. Chemical communication among bacteria. Proc Natl Acad Sci USA 2003;100(Suppl 2):14549-54.
153. Haudecoeur E, Faure D. A fine control of quorum-sensing communication in Agrobacterium tumefaciens. Commun Integr Biol 2010;3:84-8.
154. Zhu J, Miller MB, Vance RE, Dziejman M, Bassler BL, Mekalanos JJ. Quorum-sensing regulators control virulence gene expression in Vibrio cholerae. Proc Natl Acad Sci USA 2002;99:3129-34.
155. Gilligan PH. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 1991;4:35-51.
156. Whiteley M, Lee KM, Greenberg EP. Identification of genes controlled by quorum sensing in Pseudomonas aeruginosa. Proc Natl Acad Sci USA 1999;96:13904-9.
157. Eberl L, Molin S, Givskov M. Surface motility of serratia liquefaciens MG1. J Bacteriol 1999;181:1703-12.
158. Eberl L, Winson MK, Sternberg C, Stewart GS, Christiansen G, Chhabra SR, et al. Involvement of N-acyl-L-hormoserine lactone autoinducers in controlling the multicellular behaviour of Serratia liquefaciens. Mol Microbiol 1996;20:127-36.
159. Kohler T, Curty LK, Barja F, van Delden C, Pechere JC. Swarming of Pseudomonas aeruginosa is dependent on cell-to-cell signaling and requires flagella and pili. J Bacteriol 2000;182:5990-6.
160. Huber B, Riedel K, Hentzer M, Heydorn A, Gotschlich A, Givskov M, et al. The cep quorum-sensing system of Burkholderia cepacia H111 controls biofilm formation and swarming motility. Microbiology 2001;147(Pt 9):2517-28.
161. Magnuson R, Solomon J, Grossman AD. Biochemical and genetic characterization of a competence pheromone from Bacillus subtilis. Cell 1994;77:207-16.
162. Diggle SP, Winzer K, Chhabra SR, Worrall KE, Camara M, Williams P. The Pseudomonas aeruginosa quinolone signal molecule overcomes the cell density-dependency of the quorum sensing hierarchy, regulates rhl-dependent genes at the onset of stationary phase and can be produced in the absence of LasR. Mol Microbiol 2003;50:29-43.
163. Diggle SP, Cornelis P, Williams P, Camara M. 4-quinolone signalling in Pseudomonas aeruginosa: old molecules, new perspectives. Int J Med Microbiol 2006;296:83-91.
164. Williams P, Camara M. Quorum sensing and environmental adaptation in Pseudomonas aeruginosa: a tale of regulatory networks and multifunctional signal molecules. Curr Opin Microbiol 2009;12:182-91.
165. Federle MJ, Bassler BL. Interspecies communication in bacteria. J Clin Invest 2003;112:1291-9.
166. Qin X, Singh KV, Weinstock GM, Murray BE. Effects of Enterococcus faecalis fsr genes on production of gelatinase and a serine protease and virulence. Infect Immun 2000;68:2579-86.
167. Thoendel M, Horswill AR. Identification of Staphylococcus aureus AgrD residues required for autoinducing peptide biosynthesis. J Biol Chem 2009;284:21828-38.
168. Caldwell DE, Overbeck J. The planktonic microflora of lakes. CRC Crit Rev Microbiol 1977;5:305-70.
169. Isaacs JD. The nature of oceanic life. Sci Am 1969;221:146-62.
170. Geesey GG, Richardson WT, Yeomans HG, Irvin RT, Costerton JW. Microscopic examination of natural sessile bacterial populations from an alpine stream. Can J Microbiol 1977;23:1733-6.
171. Qian PY, Lau SC, Dahms HU, Dobretsov S, Harder T. Marine biofilms as mediators of colonization by marine macroorganisms: implications for antifouling and aquaculture. Mar Biotechnol 2007;9:399-410.
172. Moritz MM, Flemming HC, Wingender J. Integration of Pseudomonas aeruginosa and Legionella pneumophila in drinking water biofilms grown on domestic plumbing materials. Int J Hyg Environ Health 2010;213:190-7.
173. Wagner M, Loy A, Nogueira R, Purkhold U, Lee N, Daims H. Microbial community composition and function in wastewater treatment plants. Antonie Van Leeuwenhoek 2002;81:665-80.
174. Kelstrup J, Funder-Nielsen TD, Theilade J. Microbial aggregate contamination of water lines in dental equipment and its control. Acta Pathol Microbiol Scand B 1977;85:177-83.
175. Larsen T, Marker OT, Løie-Andersen A, Gravesen J. Vandkvaliteten i danske dentalunits med og uden kimanlæg. Tandlægebladet 2008;112:1316-22.
176. Klausen MM, Thomsen TR, Nielsen JL, Mikkelsen LH, Nielsen PH. Variations in microcolony strength of probe-defined bacteria in activated sludge flocs. FEMS Microbiol Ecol 2004;50:123-32.
177. Okabe S, Itoh T, Satoh H, Watanabe Y. Analyses of spatial distributions of sulfate-reducing bacteria and their activity in aerobic wastewater biofilms. Appl Environ Microbiol 1999;65:5107-16.
178. Okabe S, Satoh H, Watanabe Y. In situ analysis of nitrifying biofilms as determined by in situ hybridization and the use of microelectrodes. Appl Environ Microbiol 1999;65:3182-91.
179. Harmsen HJ, Kengen HM, Akkermans AD, Stams AJ, de Vos WM. Detection and localization of syntrophic propionate-oxidizing bacteria in granular sludge by in situ hybridization using 16S rRNA-based oligonucleotide probes. Appl Environ Microbiol 1996;62:1656-63.
180. 2S in photosynthetic biofilms determined by oligonucleotide probes and microelectrodes. Appl Environ Microbiol 1993;59:3840-9.
181. Watt M, Hugenholtz P, White R, Vinall K. Numbers and locations of native bacteria on field-grown wheat roots quantified by fluorescence in situ hybridization (FISH). Environ Microbiol 2006;8:871-84.
182. Yan Z, Reddy MS, Ryu CM, McInroy JA, Wilson M, Kloepper JW. Induced systemic protection against tomato late blight elicited by plant growth-promoting rhizobacteria. Phytopathology 2002;92:1329-33.
183. Kloepper JW, Ryu CM, Zhang S. Induced systemic resistance and promotion of plant growth by Bacillus spp. Phytopathology 2004;94:1259-66.
184. Rudrappa T, Biedrzycki ML, Bais HP. Causes and consequences of plant-associated biofilms. FEMS Microbiol Ecol 2008;64:153-66.
185. Theilade E, Theilade J. Bacteriology and ultrastructural studies of developing dental plaque. In: McHugh W, editor. Denal Plaque. Dundee: Thomson& Co, 1970: 27-40.
186. Listgarten MA, Mayo HE, Tremblay R. Development of dental plaque on epoxy resin crowns in man. A light and electron microscopic study. J Periodontol 1975;46:10-26.
187. Chalmers NI, Palmer RJ Jr, Cisar JO, Kolenbrander PE. Characterization of a Streptococcus sp.-Veillonella sp. community micromanipulated from dental plaque. J Bacteriol 2008;190:8145-54.
188. Diaz PI, Chalmers NI, Rickard AH, Kong C, Milburn CL, Palmer RJ Jr, et al. Molecular characterization of subject-specific oral microflora during initial colonization of enamel. Appl Environ Microbiol 2006;72:2837-48.
189. Palmer RJ Jr, Gordon SM, Cisar JO, Kolenbrander PE. Coaggregation-mediated interactions of streptococci and actinomyces detected in initial human dental plaque. J Bacteriol 2003;185:3400-9.
190. Nyvad B. Microbial colonization of human tooth surfaces. APMIS Suppl 1993;32:1-45.
191. Marsh PD. Microbial ecology of dental plaque and its significance in health and disease. Adv Dent Res 1994;8:263-71.
192. Takahashi N, Nyvad B. Caries ecology revisited: microbial dynamics and the caries process. Caries Res 2008;42:409-18.
193. Marcotte H, Lavoie MC. Oral microbial ecology and the role of salivary immunoglobulin A. Microbiol Mol Biol Rev 1998;62:71-109.
194. Dige I, Raarup MK, Nyengaard JR, Kilian M, Nyvad B. Actinomyces naeslundii in initial dental biofilm formation. Microbiology 2009;155(Pt 7):2116-26.
195. Dige I, Nilsson H, Kilian M, Nyvad B. In situ identification of streptococci and other bacteria in initial dental biofilm by confocal laser scanning microscopy and fluorescence in situ hybridization. Eur J Oral Sci 2007;115:459-67.
196. Socransky SS, Haffajee AD. Periodontal microbial ecology. Periodontol 2000 2005;38:135-87.
197. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science 2005;308:1635-8.
198. Rolhion N, rfeuille-Michaud A. Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm Bowel Dis 2007;13:1277-83.
199. Rosenfeldt V, Michaelsen KF, Jakobsen M, Larsen CN, Moller PL, Pedersen P, et al. Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea. Pediatr Infect Dis J 2002;21:411-6.
200. Zoetendal EG, Ben-Amor K, Harmsen HJ, Schut F, Akkermans AD, de Vos WM. Quantification of uncultured Ruminococcus obeum-like bacteria in human fecal samples by fluorescent in situ hybridization and flow cytometry using 16S rRNA-targeted probes. Appl Environ Microbiol 2002;68:4225-32.
201. Domingue PA, Sadhu K, Costerton JW, Bartlett K, Chow AW. The human vagina: normal flora considered as an in situ tissue-associated, adherent biofilm. Genitourin Med 1991;67:226-31.
202. Costerton JW. The microbiology of the healthy human body. In: Eckey C, editor. The Biofilm Primer. New York: Springer, 2007;107-27.
203. Sung JY, Leung JW, Shaffer EA, Lam K, Costerton JW. Bacterial biofilm, brown pigment stone and blockage of biliary stents. J Gastroenterol Hepatol 1993;8:28-34.
204. Foxman B, Goldberg D, Murdock C, Xi C, Gilsdorf JR. Conceptualizing human microbiota: from multicelled organ to ecological community. Interdiscip Perspect Infect Dis 2008;2008:613979.
205. Malcolm SA, Hughes TC. The demonstration of bacteria on and within the stratum corneum using scanning electron microscopy. Br J Dermatol 1980;102:267-75.
206. Bojar R, Holland K. The human cutaneous microflora and factors controlling colonisation. World J Microbiol Biotechnol 2002;18:889-903.
207. Høiby N, Skinhoj P. Klinisk mikrobiologi og infektionsmedicin, 3rd ed. Copenhagen: FADLs Forlag A/S, 2008.
208. Sekirov I, Finlay BB. Human and microbe: united we stand. Nat Med 2006;12:736-7.
209. Wolcott RD, Rhoads DD, Bennett ME, Wolcott BM, Gogokhia L, Costerton JW, et al. Chronic wounds and the medical biofilm paradigm. J Wound Care 2010;19:52.
210. Marsh PD. Dental plaque as a biofilm: the significance of pH in health and caries. Compend Contin Educ Dent 2009;30:76-7.
211. Hodson JJ. A histopathological study of the bacterial plaque in relation to the destruction of enamel, dentine and bone with special reference to dental caries. Proc R Soc Med 1955;48:641-52.
212. Boyde A, Lester KS. A method of preparing bacterial plaque lining carious cavities for examination by scanning electron microscopy. Arch Oral Biol 1968;13:1413-9.
213. Theilade J. Development of bacterial plaque in the oral cavity. J Clin Periodontol 1977;4:1-12.
214. Berthold P, Listgarten MA. Distribution of Actinobacillus actinomycetemcomitans in localized juvenile periodontitis plaque: an electron immunocytochemical study. J Periodontal Res 1986;21:473-85.
215. Zijnge V, van Leeuwen MB, Degener JE, Abbas F, Thurnheer T, Gmur R, et al. Oral biofilm architecture on natural teeth. PLoS ONE 2010;5:e9321.
216. Lam J, Chan R, Lam K, Costerton JW. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun 1980;28:546-56.
217. James GA, Swogger E, Wolcott R, Pulcini ED, Secor P, Sestrich J, et al. Biofilms in chronic wounds. Wound Repair Regen 2008;16:37-44.
218. Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L, Nguyen D, Hayes J, et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 2006;296:202-11.
219. Marrie TJ, Nelligan J, Costerton JW. A scanning and transmission electron microscopic study of an infected endocardial pacemaker lead. Circulation 1982;66:1339-41.
220. Waar K, Degener JE, van Luyn MJ, Harmsen HJ. Fluorescent in situ hybridization with specific DNA probes offers adequate detection of Enterococcus faecalis and Enterococcus faecium in clinical samples. J Med Microbiol 2005;54(Pt 10):937-44.
221. Marrie TJ, Noble MA, Costerton JW. Examination of the morphology of bacteria adhering to peritoneal dialysis catheters by scanning and transmission electron microscopy. J Clin Microbiol 1983;18:1388-98.
222. Marrie TJ, Costerton JW. Scanning and transmission electron microscopy of in situ bacterial colonization of intravenous and intraarterial catheters. J Clin Microbiol 1984;19:687-93.
223. Stoodley P, Braxton EE Jr, Nistico L, Hall-Stoodley L, Johnson S, Quigley M, et al. Direct demonstration of Staphylococcus biofilm in an external ventricular drain in a patient with a history of recurrent ventriculoperitoneal shunt failure. Pediatr Neurosurg 2010;46:127-32.
224. Parsa K, Schaudinn C, Gorur A, Sedghizadeh PP, Johnson T, Tse DT, et al. Demonstration of bacterial biofilms in culture-negative silicone stent and jones tube. Ophthal Plast Reconstr Surg 2010;26:426-30.
225. Gristina AG, Oga M, Webb LX, Hobgood CD. Adherent bacterial colonization in the pathogenesis of osteomyelitis. Science 1985;228:990-3.
226. Marrie TJ, Costerton JW. Mode of growth of bacterial pathogens in chronic polymicrobial human osteomyelitis. J Clin Microbiol 1985;22:924-33.
227. Cryer J, Schipor I, Perloff JR, Palmer JN. Evidence of bacterial biofilms in human chronic sinusitis. ORL J Otorhinolaryngol Relat Spec 2004;66:155-8.
228. Sanclement JA, Webster P, Thomas J, Ramadan HH. Bacterial biofilms in surgical specimens of patients with chronic rhinosinusitis. Laryngoscope 2005;115:578-82.
229. Sanderson AR, Leid JG, Hunsaker D. Bacterial biofilms on the sinus mucosa of human subjects with chronic rhinosinusitis. Laryngoscope 2006;116:1121-6.
230. Li H, Wang D, Sun X, Hu L, Yu H, Wang J. Relationship between bacterial biofilm and clinical features of patients with chronic rhinosinusitis. Eur Arch Otorhinolaryngol 2012;Jan;269(1):155-63.
231. Stewart JA, Silimperi D, Harris P, Wise NK, Fraker TD Jr, Kisslo JA. Echocardiographic documentation of vegetative lesions in infective endocarditis: clinical implications. Circulation 1980;61:374-80.
232. Poyart C, Lambert T, Morand P, Abassade P, Quesne G, Baudouy Y, et al. Native valve endocarditis due to Enterococcus hirae. J Clin Microbiol 2002;40:2689-90.
233. Nickel JC, Costerton JW. Coagulase-negative staphylococcus in chronic prostatitis. J Urol 1992;147:398-400.
234. Nickel JC, Costerton JW. Bacterial localization in antibiotic-refractory chronic bacterial prostatitis. Prostate 1993;23:107-14.
235. Reid G, Potter P, Delaney G, Hsieh J, Nicosia S, Hayes K. Ofloxacin for the treatment of urinary tract infections and biofilms in spinal cord injury. Int J Antimicrob Agents 2000;13:305-7.
236. Stapleton F, Dart J. Pseudomonas keratitis associated with biofilm formation on a disposable soft contact lens. Br J Ophthalmol 1995;79:864-5.
237. Macfarlane S, Dillon JF. Microbial biofilms in the human gastrointestinal tract. J Appl Microbiol 2007;102:1187-96.
238. Davies CE, Hill KE, Wilson MJ, Stephens P, Hill CM, Harding KG, et al. Use of 16S ribosomal DNA PCR and denaturing gradient gel electrophoresis for analysis of the microfloras of healing and nonhealing chronic venous leg ulcers. J Clin Microbiol 2004;42:3549-57.
239. Gjodsbol K, Christensen JJ, Karlsmark T, Jorgensen B, Klein BM, Krogfelt KA. Multiple bacterial species reside in chronic wounds: a longitudinal study. Int Wound J 2006;3:225-31.
240. Dowd SE, Sun Y, Secor PR, Rhoads DD, Wolcott BM, James GA, et al. Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 2008;8:43.
241. Davis SC, Ricotti C, Cazzaniga A, Welsh E, Eaglstein WH, Mertz PM. Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo. Wound Repair Regen 2008;16:23-9.
242. Gottrup F, Jorgensen B, Karlsmark T. News in wound healing and management. Curr Opin Support Palliat Care 2009;3:300-4.
243. Frankel YM, Melendez JH, Wang NY, Price LB, Zenilman JM, Lazarus GS. Defining wound microbial flora: molecular microbiology opening new horizons. Arch Dermatol 2009;145:1193-5.
244. Price LB, Liu CM, Melendez JH, Frankel YM, Engelthaler D, Aziz M, et al. Community analysis of chronic wound bacteria using 16S rRNA gene-based pyrosequencing: impact of diabetes and antibiotics on chronic wound microbiota. PLoS ONE 2009;4:e6462.
245. Thomsen TR, Aasholm MS, Rudkjobing VB, Saunders AM, Bjarnsholt T, Givskov M, et al. The bacteriology of chronic venous leg ulcer examined by culture-independent molecular methods. Wound Repair Regen 2010;18:38-49.
246. Madsen SM, Westh H, Danielsen L, Rosdahl VT. Bacterial colonization and healing of venous leg ulcers. APMIS 1996;104:895-9.
247. Halbert AR, Stacey MC, Rohr JB, Jopp-McKay A. The effect of bacterial colonization on venous ulcer healing. Australas J Dermatol 1992;33:75-80.
248. Hogsberg T, Bjarnsholt T, Thomsen JS, Kirketerp-Moller K. Success rate of split-thickness skin grafting of chronic venous leg ulcers depends on the presence of Pseudomonas aeruginosa: a retrospective study. PLoS ONE 2011;6:e20492.
249. Silverstein A, Donatucci CF. Bacterial biofilms and implantable prosthetic devices. Int J Impot Res 2003;15(Suppl 5):S150-4.
250. Percival SL, Bowler PG. Biofilms and their potential role in wound healing. Wounds 2004;16(7).
251. Davis SC, Martinez L, Kirsner R. The diabetic foot: the importance of biofilms and wound bed preparation. Curr Diab Rep 2006;6:439-45.
252. Mertz PM. Cutaneous biofilms: friend or foe? Wounds 2003;15:129-32.
253. Fazli M, Bjarnsholt T, Kirketerp-Moller K, Jorgensen B, Andersen AS, Krogfelt K, et al. Non-Random Distribution of Pseudomonas aeruginosa and Staphylococcus aureus in Chronic Wounds. J Clin Microbiol 2009;47:4084-9.
254. Koch C. Early infection and progression of cystic fibrosis lung disease. Pediatr Pulmonol 2002;34:232-6.
255. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003;168:918-51.
256. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245:1073-80.
257. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-73.
258. Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989;245:1059-65.
259. Boucher RC. An overview of the pathogenesis of cystic fibrosis lung disease. Adv Drug Deliv Rev 2002;54:1359-71.
260. Donaldson SH, Boucher RC. Update on pathogenesis of cystic fibrosis lung disease. Curr Opin Pulm Med 2003;9:486-91.
261. Knowles MR, Boucher RC. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 2002;109:571-7.
262. Szaff M, Høiby N, Flensborg EW. Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. Acta Paediatr Scand 1983;72:651-7.
263. Høiby N, Koch C. Maintenance treatment of chronic pseudomonas aeruginosa infection in cystic fibrosis. Thorax 2000;55:349-50.
264. Hoiby N. Recent advances in the treatment of Pseudomonas aeruginosa infections in Cystic Fibrosis. BMC Med 2011;9:32.
265. Koch C, Høiby N. Pathogenesis of cystic fibrosis. Lancet 1993;341:1065-9.
266. Coker TR, Chan LS, Newberry SJ, Limbos MA, Suttorp MJ, Shekelle PG, et al. Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review. JAMA 2010;304:2161-9.
267. Pelton SI, Leibovitz E. Recent advances in otitis media. Pediatr Infect Dis J 2009;28(10 Suppl):S133-7.
268. Leach AJ, Morris PS. Antibiotics for the prevention of acute and chronic suppurative otitis media in children. Cochrane Database Syst Rev 2006;Oct 18;(4):CD004401.
269. Reid SD, Hong W, Dew KE, Winn DR, Pang B, Watt J, et al. Streptococcus pneumoniae forms surface-attached communities in the middle ear of experimentally infected chinchillas. J Infect Dis 2009;199:786-94.
270. Swords WE, Moore ML, Godzicki L, Bukofzer G, Mitten MJ, VonCannon J. Sialylation of lipooligosaccharides promotes biofilm formation by nontypeable Haemophilus influenzae. Infect Immun 2004;72:106-13.
271. Jurcisek J, Greiner L, Watanabe H, Zaleski A, Apicella MA, Bakaletz LO. Role of sialic acid and complex carbohydrate biosynthesis in biofilm formation by nontypeable Haemophilus influenzae in the chinchilla middle ear. Infect Immun 2005;73:3210-8.
272. Post JC. Direct evidence of bacterial biofilms in otitis media. Laryngoscope 2001;111:2083-94.
273. Rayner MG, Zhang Y, Gorry MC, Chen Y, Post JC, Ehrlich GD. Evidence of bacterial metabolic activity in culture-negative otitis media with effusion. JAMA 1998;279:296-9.
274. Lee MR, Pawlowski KS, Luong A, Furze AD, Roland PS. Biofilm presence in humans with chronic suppurative otitis media. Otolaryngol Head Neck Surg 2009;141:567-71.
275. Bakaletz LO. Bacterial biofilms in otitis media: evidence and relevance. Pediatr Infect Dis J 2007;26(10 Suppl):S17-9.
276. Bothwell MR, Smith AL, Phillips T. Recalcitrant otorrhea due to Pseudomonas biofilm. Otolaryngol Head Neck Surg 2003;129:599-601.
277. Hoa M, Tomovic S, Nistico L, Hall-Stoodley L, Stoodley P, Sachdeva L, et al. Identification of adenoid biofilms with middle ear pathogens in otitis-prone children utilizing SEM and FISH. Int J Pediatr Otorhinolaryngol 2009;73:1242-8.
278. Nistico L, Kreft R, Gieseke A, Coticchia JM, Burrows A, Khampang P, et al. Adenoid reservoir for pathogenic biofilm bacteria. J Clin Microbiol 2011;49:1411-20.
279. Broder KW, Cohen SR. An overview of permanent and semipermanent fillers. Plast Reconstr Surg 2006;118(3 Suppl):7S-14S.
280. Christensen L. Normal and pathologic tissue reactions to soft tissue gel fillers. Dermatol Surg 2007;33(Suppl 2):S168-75.
281. Christensen L, Breiting V, Janssen M, Vuust J, Hogdall E. Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg 2005;29:34-48.
282. Christensen L, Breiting V, Vuust J, Hogdall E. Adverse reactions following injection with a permanent facial filler polyacrylamide hydrogel (Aquamid): cause and treatment. Eur J Plast Surg 2006;28:464.
283. Christensen LH. Host tissue interaction, fate, and risks of degradable and nondegradable gel fillers. Dermatol Surg 2009;35(Suppl 2):1612-9.
284. Brady RA, Leid JG, Calhoun JH, Costerton JW, Shirtliff ME. Osteomyelitis and the role of biofilms in chronic infection. FEMS Immunol Med Microbiol 2008;52:13-22.
285. Cohen M, Kofonow J, Nayak JV, Palmer JN, Chiu AG, Leid JG, et al. Biofilms in chronic rhinosinusitis: a review. Am J Rhinol Allergy 2009;23:255-60.
286. Hunsaker DH, Leid JG. The relationship of biofilms to chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2008;16:237-41.
287. Perloff JR, Palmer JN. Evidence of bacterial biofilms on frontal recess stents in patients with chronic rhinosinusitis. Am J Rhinol 2004;18:377-80.
288. Connell H, Hedlund M, Agace W, Svanborg C. Bacterial attachment to uro-epithelial cells: mechanisms and consequences. Adv Dent Res 1997;11:50-8.
289. Yadav AB, Singh AK, Verma RK, Mohan M, Agrawal AK, Misra A. The devil's advocacy: when and why inhaled therapies for tuberculosis may not work. Tuberculosis 2011;91:65-6.
290. Trampuz A, Zimmerli W. Diagnosis and treatment of implant-associated septic arthritis and osteomyelitis. Curr Infect Dis Rep 2008;10:394-403.
291. Hansen SK, Rau MH, Johansen HK, Ciofu O, Jelsbak L, Yang L, et al. Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection. ISME J 2012;Jan;6(1):31-45.
292. Jolivet-Gougeon A, Kovacs B, Le Gall-David S, Le BH, Bousarghin L, Bonnaure-Mallet M, et al. Bacterial hypermutation: clinical implications. J Med Microbiol 2011;60(Pt 5):563-73.
293. Babb JR, Lynam P, Ayliffe GA. Risk of airborne transmission in an operating theatre containing four ultraclean air units. J Hosp Infect 1995;31:159-68.
294. Chow TT, Yang XY. Ventilation performance in operating theatres against airborne infection: review of research activities and practical guidance. J Hosp Infect 2004;56:85-92.
295. Bjarnsholt T, Givskov M. Quorum-sensing blockade as a strategy for enhancing host defences against bacterial pathogens. Philos Trans R Soc Lond B Biol Sci 2007;362:1213-22.
296. Skindersoe ME, Alhede M, Phipps R, Yang L, Jensen PO, Rasmussen TB, et al. Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2008;52:3648-63.
297. Yang L, Rybtke MT, Jakobsen TH, Hentzer M, Bjarnsholt T, Givskov M, et al. Computer-aided identification of recognized drugs as Pseudomonas aeruginosa quorum-sensing inhibitors. Antimicrob Agents Chemother 2009;53:2432-43.
298. Gao P, Nie X, Zou M, Shi Y, Cheng G. Recent advances in materials for extended-release antibiotic delivery system. J Antibiot 2011;64:625-34.
299. Hansen CR, Pressler T, Hoiby N. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. J Cyst Fibros 2008;7:523-30.
300. Høiby N, Frederiksen B, Pressler T. Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros 2005;4(Suppl 2):49-54.
301. Koch B, Liljefors T, Persson T, Nielsen J, Kjelleberg S, Givskov M. The LuxR receptor: the sites of interaction with quorum-sensing signals and inhibitors. Microbiology 2005;151(Pt 11):3589-602.
302. Frederiksen B, Koch C, Høiby N. Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995). Pediatr Pulmonol 1999;28:159-66.
303. Frederiksen B, Koch C, Høiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 1997;23:330-5.
304. Frederiksen B, Lanng S, Koch C, Høiby N. Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment. Pediatr Pulmonol 1996;21:153-8.
305. Carvalho JC, Ekstrand KR, Thylstrup A. Results after 1 year of non-operative occlusal caries treatment of erupting permanent first molars. Community Dent Oral Epidemiol 1991;19:23-8.
306. Inbakandan D, Murthy PS, Venkatesan R, Khan SA. 16S rDNA sequence analysis of culturable marine biofilm forming bacteria from a ship's hull. Biofouling 2010;26:893-9.
307. Schultz MP, Bendick JA, Holm ER, Hertel WM. Economic impact of biofouling on a naval surface ship. Biofouling 2011;27:87-98.
308. O'Toole GA, Kolter R. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol 1998;28:449-61.
309. Pedersen SS, Shand GH, Hansen BL, Hansen GN. Induction of experimental chronic Pseudomonas aeruginosa lung infection with P. aeruginosa entrapped in alginate microspheres. APMIS 1990;98:203-11.
310. Hoffmann N, Rasmussen TB, Jensen PO, Stub C, Hentzer M, Molin S, et al. Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis. Infect Immun 2005;73:2504-14.
311. Moser C, van GM, Bjarnsholt T, Jensen PO, Lee B, Hougen HP, et al. Novel experimental Pseudomonas aeruginosa lung infection model mimicking long-term host-pathogen interactions in cystic fibrosis. APMIS 2009;117:95-107.
312. Ehrlich GD, Veeh R, Wang X, Costerton JW, Hayes JD, Hu FZ, et al. Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. JAMA 2002;287:1710-5.
313. Schaber JA, Triffo WJ, Suh SJ, Oliver JW, Hastert MC, Griswold JA, et al. Pseudomonas aeruginosa forms biofilms in acute infection independent of cell-to-cell signaling. Infect Immun 2007;75:3715-21.
314. Rumbaugh KP, Carty NL. In vivo model of biofilm infections. In: Bjarnsholt T, Moser C, Jensen PO, Høiby N, editors. Biofilm Infections, 1st ed. New York: Springe, 2010: 267-90.
315. Dige I. Initial dental biofilm formation studied by confocal laser scanning microscopy and fluorescence in situ hybridization. PhD Thesis, Denmark: Faculty of Health Sciences, Aarhus University, 2008.
316. Rogers GB, Stressmann FA, Walker AW, Carroll MP, Bruce KD. Lung infections in cystic fibrosis: deriving clinical insight from microbial complexity. Expert Rev Mol Diagn 2010;10:187-96.
317. Stressmann FA, Rogers GB, Klem ER, Lilley AK, Donaldson SH, Daniels TW, et al. Analysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centers. J Clin Microbiol 2011;49:281-91.
318. Costerton JW, Post JC, Ehrlich GD, Hu FZ, Kreft R, Nistico L, et al. New methods for the detection of orthopedic and other biofilm infections. FEMS Immunol Med Microbiol 2011;Mar;61(2):133-40.
319. Hansen SK, Rainey PB, Haagensen JA, Molin S. Evolution of species interactions in a biofilm community. Nature 2007;445:533-6.
320. Jackson CR. Changes in community properties during microbial succession. Oikos 2003;101:444-8.
321. Huse HK, Kwon T, Zlosnik JE, Speert DP, Marcotte EM, Whiteley M. Parallel evolution in Pseudomonas aeruginosa over 39, 000 generations in vivo. MBio 2010;Sep 21;1(4). doi:pii: e00199-10. 10.1128/mBio.00199-10.
322. Yang L, Jelsbak L, Marvig RL, Damkiaer S, Workman CT, Rau MH, et al. Evolutionary dynamics of bacteria in a human host environment. Proc Natl Acad Sci USA 2011;108:7481-6.
323. Weller DM, Raaijmakers JM, Gardener BB, Thomashow LS. Microbial populations responsible for specific soil suppressiveness to plant pathogens. Annu Rev Phytopathol 2002;40:309-48.
324. Spadden Gardener BB, Weller DM. Changes in populations of rhizosphere bacteria associated with take-all disease of wheat. Appl Environ Microbiol 2001;67:4414-25.
325. Cook RJ, Thomashow LS, Weller DM, Fujimoto D, Mazzola M, Bangera G, et al. Molecular mechanisms of defense by rhizobacteria against root disease. Proc Natl Acad Sci USA 1995;92:4197-201.
326. Ruby J, Barbeau J. The buccale puzzle: the symbiotic nature of endogenous infections of the oral cavity. Can J Infect Dis 2002;13:34-41.
327. De Stoppelaar JD, Van HJ, Backer DO. The effect of carbohydrate restriction on the presence of Streptococcus mutans, Streptococcus sanguis and iodophilic polysaccharide-producing bacteria in human dental plaque. Caries Res 1970;4:114-23.
328. Marsh PD, Percival RS. The oral microflora-friend or foe? Can we decide? Int Dent J 2006;56(4 Suppl 1):233-9.
329. Marsh PD. Are dental diseases examples of ecological catastrophes? Microbiology 2003;149(Pt 2):279-94.
330. Marsh PD. Sugar, fluoride, pH and microbial homeostasis in dental plaque. Proc Finn Dent Soc 1991;87:515-25.
331. Veeh RH, Shirtliff ME, Petik JR, Flood JA, Davis CC, Seymour JL, et al. Detection of Staphylococcus aureus biofilm on tampons and menses components. J Infect Dis 2003;188:519-30.
332. Rieger UM, Pierer G, Luscher NJ, Trampuz A. Sonication of removed breast implants for improved detection of subclinical infection. Aesthetic Plast Surg 2009;33:404-8.
333. Fux CA, Costerton JW, Stewart PS, Stoodley P. Survival strategies of infectious biofilms. Trends Microbiol 2005;13:34-40.
334. Whiteley M, Bangera MG, Bumgarner RE, Parsek MR, Teitzel GM, Lory S, et al. Gene expression in Pseudomonas aeruginosa biofilms. Nature 2001;413:860-4.
335. Bjerkan G, Witso E, Bergh K. Sonication is superior to scraping for retrieval of bacteria in biofilm on titanium and steel surfaces in vitro. Acta Orthop 2009;80:245-50.
336. Trampuz A, Piper KE, Jacobson MJ, Hanssen AD, Unni KK, Osmon DR, et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 2007;357:654-63.
337. Rohacek M, Weisser M, Kobza R, Schoenenberger AW, Pfyffer GE, Frei R, et al. Bacterial colonization and infection of electrophysiological cardiac devices detected with sonication and swab culture. Circulation 2010;121:1691-7.
338. Kobayashi H, Oethinger M, Tuohy MJ, Procop GW, Bauer TW. Improved detection of biofilm-formative bacteria by vortexing and sonication: a pilot study. Clin Orthop Relat Res 2009;467:1360-4.
339. Kobayashi N, Bauer TW, Tuohy MJ, Fujishiro T, Procop GW. Brief ultrasonication improves detection of biofilm-formative bacteria around a metal implant. Clin Orthop Relat Res 2007;457:210-3.
340. Ripa KT. Microbiology Diagnosis of chlamydia trachomatis infection. Infection 1982;10(Suppl 1):S19-24.
341. Sampedro MF, Huddleston PM, Piper KE, Karau MJ, Dekutoski MB, Yaszemski MJ, et al. A biofilm approach to detect bacteria on removed spinal implants. Spine (Phila Pa 1976) 2010;35:1218-24.
342. Brown MR, Barker J. Unexplored reservoirs of pathogenic bacteria: protozoa and biofilms. Trends Microbiol 1999;7:46-50.
343. Parsek MR, Singh PK. Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol 2003;57:677-701.
344. Hall-Stoodley L, Stoodley P. Evolving concepts in biofilm infections. Cell Microbiol 2009;11:1034-43.
345. Brady RA, O'May GA, Leid JG, Costerton JW, Shirtliff ME. Resolution of Staphylococcus aureus biofilm infection using vaccination and antibiotic treatment. Infect Immun 2011;Apr;79(4):1797-803.
346. Brady RA, Leid JG, Camper AK, Costerton JW, Shirtliff ME. Identification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to a biofilm infection. Infect Immun 2006;74:3415-26.
347. Wilson M. The Respiratory System and its Indigenous Microbiota. Microbial Inhabitants of Humans. 1st ed. New Your: Cambridge University Press, 2005: 128-78.
348. Rivers TM. Viruses and Koch's Postulates. J Bacteriol 1937;33:1-12.
349. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300.
350. Fredericks DN, Relman DA. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin Microbiol Rev 1996;9:18-33.
351. Evans AS. Causation and disease: the Henle-Koch postulates revisited. Yale J Biol Med 1976;49:175-95.
352. Høiby N, Flensborg EW, Beck B, Friis B, Jacobsen SV, Jacobsen L. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. Scand J Respir Dis 1977;58:65-79.
353. Høiby N, Wiik A. Antibacterial precipitins and autoantibodies in serum of patients with cystic fibrosis. Scand J Respir Dis 1975;56:38-46.
354. Hoiby N, Doring G, Schiotz PO. The role of immune complexes in the pathogenesis of bacterial infections. Annu Rev Microbiol 1986;40:29-53.
355. Kjerulf A, Tvede M, Hoiby N. Crossed immunoelectrophoresis used for bacteriological diagnosis in patients with endocarditis. APMIS 1993;101:746-52.
356. Høiby N, Pressler T. Emerging patogens in cystic fibrosis. In: Webb AK, Ratjen F, editors. Cystic Fibrosis. Sheffield: European Respiratory Society Journals, 2006: 66-79.
357. Bak J, Begovic T, Bjarnsholt T, Nielsen A. A UVC device for intra-luminal disinfection of catheters: in vitro tests on soft polymer tubes contaminated with Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli and Candida albicans. Photochem Photobiol 2011;87:1123-8.
358. Andersen AS, Joergensen B, Bjarnsholt T, Johansen H, Karlsmark T, Givskov M, et al. Quorum-sensing-regulated virulence factors in Pseudomonas aeruginosa are toxic to Lucilia sericata maggots. Microbiology 2010;156(Pt 2):400-7.
359. Kownatzki R, Tummler B, Doring G. Rhamnolipid of Pseudomonas aeruginosa in sputum of cystic fibrosis patients. Lancet 1987;1:1026-7.
360. Kohler T, Guanella R, Carlet J, van DC. Quorum sensing-dependent virulence during Pseudomonas aeruginosa colonisation and pneumonia in mechanically ventilated patients. Thorax 2010;65:703-10.
361. de BS, Polette M, Zahm JM, Hinnrasky J, Kileztky C, Bajolet O, et al. Pseudomonas aeruginosa virulence factors delay airway epithelial wound repair by altering the actin cytoskeleton and inducing overactivation of epithelial matrix metalloproteinase-2. Lab Invest 2000;80:209-19.
362. Ikema K, Matsumoto K, Inomata Y, Komohara Y, Miyajima S, Takeya M, et al. Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis. Exp Eye Res 2006;83:1396-404.
363. Lobmann R, Schultz G, Lehnert H. Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications. Diabetes Care 2005;28:461-71.
364. Lobmann R. Cytokine analyses in wound fluids of DFS: an objective reflection of inflammation and the state of healing. 2005. DFSG annual meeting 2005, abstract number 07.
365. Gaggar A, Li Y, Weathington N, Winkler M, Kong M, Jackson P, et al. Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients. Am J Physiol Lung Cell Mol Physiol 2007;293:L96-104.
366. Dong Z, Ghabrial M, Katar M, Fridman R, Berk RS. Membrane-type matrix metalloproteinases in mice intracorneally infected with Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci 2000;41:4189-94.
367. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993;122:1-9.
368. Emerson J, McNamara S, Buccat AM, Worrell K, Burns JL. Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008. Pediatr Pulmonol 2010;45:363-70.
369. Pedersen SS, Kharazmi A, Espersen F, Høiby N. Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response. Infect Immun 1990;58:3363-8.
370. Pressler T, Jensen ET, Espersen F, Pedersen SS, Høiby N, Koch C. Correlation between specific IgG subclass antibodies to Pseudomonas aeruginosa and opsonic activity in serum from patients with cystic fibrosis. Pediatr Pulmonol 1994;17:31-40.
371. Pressler T, Jensen ET, Espersen F, Pedersen SS, Høiby N. High levels of complement-activation capacity in sera from patients with cystic fibrosis correlate with high levels of IgG3 antibodies to Pseudomonas aeruginosa antigens and poor lung function. Pediatr Pulmonol 1995;20:71-7.
372. Pressler T, Mansa B, Jensen T, Pedersen SS, Hoiby N, Koch C. Increased IgG2 and IgG3 concentration is associated with advanced Pseudomonas aeruginosa infection and poor pulmonary function in cystic fibrosis. Acta Paediatr Scand 1988;77:576-82.
373. Pressler T, Frederiksen B, Skov M, Garred P, Koch C, Hoiby N. Early rise of anti-pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection-a case control study. J Cyst Fibros 2006;5:9-15.
374. Pedersen SS, Espersen F, Høiby N, Jensen T. Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis. J Clin Microbiol 1990;28:747-55.
375. Jones AP, Wallis C. Dornase alfa for cystic fibrosis. Cochrane Database Syst Rev 2010;Mar 17;(3):CD001127. doi: 10.1002/14651858.CD001127.pub2.
376. Hansen CR, Pressler T, Koch C, Høiby N. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study. J Cyst Fibros 2005;4:35-40.
377. Kronborg G, Pressler T, Fomsgaard A, Koch C, Høiby N. Specific IgG2 antibodies to Pseudomonas aeruginosa lipid A and lipopolysaccharide are early markers of chronic infection in patients with cystic fibrosis. Infection 1993;21:297-302.
378. Kronborg G, Fomsgaard A, Galanos C, Freudenberg MA, Hoiby N. Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients. J Clin Microbiol 1992;30:1848-55.
379. Doring G, Goldstein W, Botzenhart K, Kharazmi A, Schiotz PO, Høiby N, et al. Elastase from polymorphonuclear leucocytes: a regulatory enzyme in immune complex disease. Clin Exp Immunol 1986;64:597-605.
380. Bagge N, Schuster M, Hentzer M, Ciofu O, Givskov M, Greenberg EP, et al. Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production. Antimicrob Agents Chemother 2004;48:1175-87.
381. Valerius NH, Koch C, Høiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 1991;338:725-6.